AbCellera Biologics Inc. - Ordinary Shares (ABCL) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2025

Type / Class
Equity / Ordinary Shares
Symbol
ABCL on Nasdaq
Shares outstanding
293,061,432
Price per share
$3.42
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
104,032,627
Total reported value
$524,646,193
% of total 13F portfolios
0%
Share change
-3,738,353
Value change
+$3,617,959
Number of holders
140
Price from insider filings
$3.42
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AbCellera Biologics Inc. - Ordinary Shares (ABCL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAILLIE GIFFORD & CO 4.4% $32,881,493 12,894,703 BAILLIE GIFFORD & CO 30 Sep 2024

As of 30 Sep 2025, 140 institutional investors reported holding 104,032,627 shares of AbCellera Biologics Inc. - Ordinary Shares (ABCL). This represents 35% of the company’s total 293,061,432 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of AbCellera Biologics Inc. - Ordinary Shares (ABCL) together control 33% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BAKER BROS. ADVISORS LP 9.4% 27,525,640 0% 1% $138,453,969
Capital World Investors 4.6% 13,361,096 0% 0.01% $67,206,313
BAILLIE GIFFORD & CO 3.6% 10,422,966 +0.61% 0.04% $52,427,519
TWO SIGMA INVESTMENTS, LP 1.8% 5,175,142 +26% 0.04% $26,030,964
TWO SIGMA ADVISERS, LP 1.6% 4,799,900 +18% 0.05% $24,143,497
ArrowMark Colorado Holdings LLC 1.4% 4,105,095 0% 0.38% $20,648,628
BlackRock, Inc. 1.2% 3,641,779 -1.1% 0% $18,318,147
RENAISSANCE TECHNOLOGIES LLC 1.1% 3,360,729 +1.6% 0.02% $16,904,467
MORGAN STANLEY 0.95% 2,792,142 +180% 0% $14,044,475
TANG CAPITAL MANAGEMENT LLC 0.89% 2,600,000 0% 0.5% $13,078,000
UBS Group AG 0.85% 2,489,200 -28% 0% $12,520,677
MILLENNIUM MANAGEMENT LLC 0.83% 2,429,736 -28% 0.01% $12,221,572
BANK OF AMERICA CORP /DE/ 0.83% 2,418,304 +978% 0% $12,164,069
Guardian Partners Inc. 0.61% 1,786,414 0% 0.9% $10,647,027
Driehaus Capital Management LLC 0.59% 1,726,941 +245% 0.06% $8,686,513
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.48% 1,418,533 +139% 0.01% $7,135,221
CITADEL ADVISORS LLC 0.34% 1,008,615 -65% 0% $5,073,333
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.25% 736,945 0% $3,706,833
TUDOR INVESTMENT CORP ET AL 0.25% 730,122 0.02% $3,672,514
Jump Financial, LLC 0.23% 675,600 0.04% $3,398,268
STATE STREET CORP 0.23% 671,017 +9.2% 0% $3,375,216
DNB ASSET MANAGEMENT AS 0.22% 656,208 0.01% $3,300,726
LAZARD ASSET MANAGEMENT LLC 0.22% 652,096 +28% 0% $3,280,043
Intellectus Partners, LLC 0.19% 543,133 -0.91% 0.53% $2,731,958
ROYAL BANK OF CANADA 0.17% 503,964 +25% 0% $2,535,000

Institutional Holders of AbCellera Biologics Inc. - Ordinary Shares (ABCL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 123,559 $422,636 -$93,490 $3.42 8
2025 Q3 104,032,627 $524,646,193 +$3,617,959 $5.03 140
2025 Q2 107,623,463 $370,594,083 -$42,109,114 $3.43 127
2025 Q1 124,693,841 $278,605,461 +$21,793,003 $2.23 127
2024 Q4 113,909,183 $333,909,974 +$23,930,958 $2.93 145
2024 Q3 105,626,999 $274,569,746 -$27,524,912 $2.60 139
2024 Q2 114,251,365 $337,827,363 -$12,985,717 $2.96 146
2024 Q1 120,885,782 $546,343,961 +$6,435,245 $4.53 153
2023 Q4 119,177,804 $681,087,686 -$3,743,767 $5.71 141
2023 Q3 120,025,395 $551,791,208 -$29,473,838 $4.60 137
2023 Q2 124,831,655 $809,068,808 -$42,715,484 $6.46 167
2023 Q1 130,072,488 $980,706,858 +$9,956,814 $7.54 181
2022 Q4 138,959,875 $1,408,301,843 +$64,970,441 $10.13 198
2022 Q3 132,080,272 $1,309,587,378 +$125,586,082 $9.89 185
2022 Q2 117,984,795 $1,259,732,308 +$77,596,210 $10.65 160
2022 Q1 113,127,329 $1,100,172,856 -$30,931,776 $9.75 126
2021 Q4 114,533,051 $1,628,519,417 +$98,165,187 $14.30 120
2021 Q3 98,697,276 $1,977,505,786 +$155,909,310 $20.04 115
2021 Q2 90,556,840 $1,986,081,198 +$169,321,459 $22.00 111
2021 Q1 71,121,706 $2,415,006,720 +$64,105,935 $33.96 82
2020 Q4 68,103,635 $2,740,470,000 +$2,587,818,000 $40.24 58